← Today’s edition

legal · Europe / UK

Brains Bioceutical To List On NASDAQ Via SPAC At US$750m Valuation

Editorial image for Brains Bioceutical To List On NASDAQ Via SPAC At US$750m Valuation
51

🌿 Plant Truth Index

Factual Record

Progressive0%
Rigour5%
Local20%

90+ Stigma Breaker · 70+ Plant Forward · 40+ Factual Record · below 40 Prohibition Echo

Brains Bioceutical Corp. has announced plans to list on Nasdaq, in what would be the first US public-market debut for a UK-based cannabinoid pharma manufacturer since GW Pharmaceuticals was acquired by Jazz in 2021. The company, headquartered in Vancouver, British Columbia, operates one of the largest cannabinoid active pharmaceutical ingredient (API) manufacturing facilities in the […]

Why DaggaBay rated it this way

Filed as Market intelligence — a industry & market story with objective record framing.

5%

Evidence rigour

20%

Local impact

0

Evidence and watchdog value

No strong framing phrases were detected.